Riskpilot← Back to searchSign inGet full accessTS Vård & Hälsa AB
ABActiveOrg 5591131007Anders Möllares Väg 2 AHospital activities · NACE 8610Est. 20171 employees
Revenue 2025
SEK 430K
+33% vs 2024
EBITDA margin
67.5%
+41% vs 2024
Equity ratio
78.3%
Financial strength
Net profit 2025
SEK 197K
+51% vs 2024
| Revenue | SEK 430K | +33% |
| EBITDA | SEK 290K | +41% |
| Net profit | SEK 197K | +51% |
| Total assets | SEK 663K | +11% |
| Equity | SEK 519K | +0% |
| Employees | 1 | — |
Legal name
TS Vård & Hälsa AB
Org number
5591131007
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
22 maj 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Anders Möllares Väg 2 A
Email
tatara_safi@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 496 | 441 | 573 | 322 | 430 |
| Staff expenses | — | −42 | −51 | −48 | −48 |
| EBITDA | 306 | 263 | 333 | 205 | 290 |
| Depreciation & amort. | −0 | — | −40 | −40 | −40 |
| EBIT | 306 | 263 | 293 | 165 | 250 |
| Net financials | — | −0 | −0 | −1 | 1 |
| Profit before tax | 306 | 263 | 293 | 165 | 251 |
| Tax | −63 | −54 | −60 | −34 | −54 |
| Net profit | 243 | 209 | 232 | 131 | 197 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 611 | 686 | 708 | 597 | 663 |
| Equity | 421 | 480 | 536 | 517 | 519 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 189 | 207 | 172 | 80 | 144 |
| Total debt | 189 | 207 | 172 | 80 | 144 |
EBITDA margin
67.5%
This company
15.8%
Market median
+327% vs market
20212025
Equity ratio
78.3%
This company
38.2%
Market median
+105% vs market
20212025
Return on equity
38.0%
This company
18.4%
Market median
+107% vs market
20212025
Net profit margin
45.9%
This company
8.1%
Market median
+467% vs market
20212025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20212025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TS Vård & Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tatara Delavaran | Board of Directors | 0 companies |
| Sam Delavaran | Deputy Board Member | 0 companies |
| Khalilullah Safi | Deputy Board Member | 0 companies |